Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2010
12/29/2010EP2266606A1 Methods and compositions for the prevention and treatment of sepsis
12/29/2010EP2266600A2 Therapeutic composition with a botulinum neurotoxin
12/29/2010EP2266599A2 Therapeutic composition with a botulinum neurotoxin
12/29/2010EP2266598A1 Method of increasing bone toughness and stiffness and reducing fractures
12/29/2010EP2266597A1 Control of blood glucose in diabetes treatment using pulmonarily administered insulin in combination with basal insulin
12/29/2010EP2266596A1 Pharmaceutical composition and a method for the production thereof
12/29/2010EP2266595A2 Treatment of infections and other disorders
12/29/2010EP2266594A1 VEGF for use in the treatment of central nervous system disorders
12/29/2010EP2266593A1 Use of CD44v6 in the treatment of ophthalmic diseases
12/29/2010EP2266592A2 Protective proteins of S. agalactiae, combinations thereof and methods of using the same
12/29/2010EP2266591A2 Protective proteins of S. agalactiae, combinations thereof and methods of using the same
12/29/2010EP2266590A2 Active agent delivery sytems and methods for protecting and administering active agents
12/29/2010EP2266588A1 Method for cancer therapy based on co-administration of a parovirus and a cytokine
12/29/2010EP2266586A1 Compositions and method for alleviating inflammation and oxidative stress in a mammal
12/29/2010EP2266568A1 Use of LHRH antagonists in combination with PDE V inhibitors for the treatment of sex hormone dependent disorders
12/29/2010EP2266567A1 Use of cetrorelix in combination with PDE V inhibitors for the treatment of sex hormone dependent disorders
12/29/2010EP2266552A2 Methods of inducing terminal differentiation
12/29/2010EP2266550A1 Antagonists of ß-catenin for preventing and/or treating neurodegenerative disorders
12/29/2010EP2266548A2 Dry powder for inhalation
12/29/2010EP2266543A2 Non-polymeric hematopoietic cell clots for delivery of active agents
12/29/2010EP2266535A2 Controlled release compositions for interferon based on block polymers
12/29/2010EP2266534A1 Aerosolized fosfomycin/aminoglycoside combination for the treatment of bacterial respiratory infections
12/29/2010EP2265954A1 Immunotherapeutic methods and molecules
12/29/2010EP2265728A1 Hemostatic microspheres
12/29/2010EP2265638A1 Stable cell binding chimeric peptides
12/29/2010EP2265636A1 Mzb1, a novel b cell factor, and uses thereof
12/29/2010EP2265635A1 Modified cpn10 and prr signalling
12/29/2010EP2265631A2 Novel antimicrobial peptides and their application
12/29/2010EP2265630A2 Plectin-1 targeted agents for detection and treatment of pancreatic ductal adenocarcinoma
12/29/2010EP2265282A1 Novel crustacean androgenic gland hormone
12/29/2010EP2265281A2 Use of interleukin-1 conjugates in the treatment of diabetes
12/29/2010EP2265280A2 Preparation of a pharmaceutical composition for increasing bone mineral density
12/29/2010EP2265279A1 Use of the pat nonapeptide in the treatment of autoimmune diseases
12/29/2010EP2265278A1 A composition for treatment and improvement of diabetes comprising caveolin as active ingredient and a method for treatment of diabetes using it
12/29/2010EP2265113A1 Use of ferritin to treat iron deficiency disorders
12/29/2010EP2142174B1 Stable aqueous g-csf formulations
12/29/2010EP2049091B1 Casein complexes
12/29/2010EP1992638B1 Immunomodulatory and anti-tumour peptides
12/29/2010EP1856153B1 Ykl-40 monoclonal antibodies
12/29/2010EP1771199B1 Long-acting colloidal insulin formulation and preparation thereof
12/29/2010EP1748789B1 IL-22 for preventing infectious diseases
12/29/2010EP1725244B1 Method of preventing fibrin clots in pulmonary tissue through the use of aerosolized anticoagulants
12/29/2010EP1685405B1 Angiogenesis inhibiting molecules and their use in the treatment and diagnosis of cancer
12/29/2010EP1560558B1 Use of 3-position cyclosporin derivatives for hair growth
12/29/2010EP1539228B1 Novel composition and methods for the treatment of immune related diseases
12/29/2010EP1529062B1 Therapeutic use of kremen 1 and 2, inhibitors of the canonical wnt-signal transduction
12/29/2010EP1494705B1 A composition and method for killing of tumours
12/29/2010EP1425305B1 Igf-1 as feline vaccine adjuvant, in particular against feline retroviruses
12/29/2010EP1315519B1 Pharmaceutical compositions and methods useful for treating cancer or liver fibrosis
12/29/2010EP1286657B1 Nasal ointment based on white petroleum jelly
12/29/2010EP1127069B1 Method of making a monomeric beta-form of a prion protein
12/29/2010EP1107722B1 A method for the treatment of staphylococcal infection
12/29/2010EP1077678B1 Mucoadhesive compositions for administration of biologically active agents to animal tissue
12/29/2010CN1995345B Recombinant L-251 protein with anti-inflammatory effect secreted by Japanese lamprey oral gland
12/29/2010CN1968691B Composition for acceleration of alcohol metabolism or recuperation from fatigue through gluconeogenesis
12/29/2010CN1956707B Gastroresistant pharmaceutical dosage form comprising N-(2-(2-phthalimidoethoxy)-acetyl)-l-alanyl-D-glutamic acid (LK-423)
12/29/2010CN1948342B HLA-A2 restriction epi polypeptide originated from post selection cancer gene hRabj and its application
12/29/2010CN1929861B CTGF as target for the therapy of diabetic nephropathy
12/29/2010CN1893911B Formula including tetrapeptide and tripeptide mixture
12/29/2010CN1863558B Polyarginine-modified liposome capable of transferring into nucleus
12/29/2010CN1856504B Anti-infarction molecules
12/29/2010CN101932609A Compositions and methods to modulate cell membrane resealing
12/29/2010CN101932601A 胰岛素衍生物 Insulin derivatives
12/29/2010CN101932599A Molecule and chimeric molecules thereof
12/29/2010CN101932592A Antitumoral compounds
12/29/2010CN101932335A Medicament for the treatment of cancer of the pancreas
12/29/2010CN101932334A Compositions for reducing dental erosion
12/29/2010CN101932333A Anti-c35 antibody combination therapies and methods
12/29/2010CN101932311A Microparticles and pharmaceutical compositions thereof
12/29/2010CN101928745A Preparation method and applications of ant polypeptide
12/29/2010CN101928743A Enzymolysis product of spirulina phycocyanin and application thereof
12/29/2010CN101928742A Whey protein active peptide with antioxidant activity and preparation method thereof
12/29/2010CN101928740A MMP14 double-target efficient binding peptide, method for obtaining polypeptide structure sequence and application of target compound
12/29/2010CN101928739A New preparation method of high-density lipoprotein
12/29/2010CN101928710A Anticoagulation molecule Rhipilin-1 gene sequence of Rhipicephalus haemaphysaloides, recombinant expression and application
12/29/2010CN101928709A Gene sequence, recombinant expression and application of hyalomma asiaticum histamine binding protein (HaHBP)
12/29/2010CN101928692A Differentiated cells suitable for human therapy
12/29/2010CN101928342A High-purity menopausal gonadotropin as well as preparation method and application thereof
12/29/2010CN101928340A Group of antibacterial peptide derivatives and application thereof
12/29/2010CN101928335A Fungus antitumor polypeptide nucleotide sequence, and preparation method and applications thereof
12/29/2010CN101928331A New compound and application thereof
12/29/2010CN101928330A New compound and application thereof
12/29/2010CN101928329A Tripeptide boric acid (ester) compound and preparation method and application thereof
12/29/2010CN101928326A Substitution five-heterocyclic alkyl aminoacyl compound and application thereof
12/29/2010CN101928241A 2-mercaptopentancarboxylic acid derivatives, the method for preparing them and the pharmaceutical compositions containing them
12/29/2010CN101926999A Hemostatic disinfectant and preparation method thereof
12/29/2010CN101926985A Lumbrokinase injection for treating thromboembolic disease
12/29/2010CN101926984A Preparation method of artificial nano red blood cells
12/29/2010CN101926983A Artificial nano red blood cells
12/29/2010CN101926982A Medicament or health-care food for increasing bone mineral density
12/29/2010CN101926981A Methods of treating neurological conditions with hematopoietic growth factors
12/29/2010CN101926980A Application of cytotoxin (CTX1) from snake venom to preparation of medicament for rehabilitating
12/29/2010CN101926979A Use of fungal immunomodulatory protein
12/29/2010CN101926978A Medicine composition for promoting bone and bony articulation health
12/29/2010CN101926824A Methods for genetic modification of hematopoietic progenitor cells and uses of the modified cells
12/29/2010CN101565703B Eriocheir sinensis Crustin-2 gene and application of recombinant protein thereof
12/29/2010CN101497886B Polypeptide of fungal thioredoxin, coding sequence, preparation and use
12/29/2010CN101401930B Polypeptide and uses in preparing anti-heart failure and anti-inflammatory reaction medicament
12/29/2010CN101319207B Site-directed mutagenesis genetic engineering batroxobin and uses thereof
12/29/2010CN101311188B Small molecule peptides inhibitor of human heparinase
1 ... 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 ... 3163